Amprius Technologies (NYSE:AMPX) Research Coverage Started at Craig Hallum

Craig Hallum initiated coverage on shares of Amprius Technologies (NYSE:AMPX) in a research note issued to investors on Monday, MarketBeat reports. The firm issued a buy rating and a $17.00 price objective on the stock.

Several other analysts have also recently weighed in on AMPX. Needham & Company LLC began coverage on shares of Amprius Technologies in a research note on Thursday, January 29th. They issued a “buy” rating and a $20.00 price objective on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Oppenheimer reissued an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, Cantor Fitzgerald lifted their price objective on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $16.63.

Amprius Technologies Stock Performance

Shares of NYSE AMPX opened at $11.06 on Monday. The firm has a 50 day moving average price of $10.32 and a two-hundred day moving average price of $10.45. The stock has a market cap of $1.44 billion, a P/E ratio of -42.54 and a beta of 2.99. Amprius Technologies has a 52-week low of $1.70 and a 52-week high of $16.03.

Insider Transactions at Amprius Technologies

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of the company’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares in the company, valued at $9,014,299.84. This represents a 39.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kang Sun sold 950,548 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $11.07, for a total value of $10,522,566.36. Following the sale, the director directly owned 1,403,651 shares of the company’s stock, valued at $15,538,416.57. This represents a 40.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,392,269 shares of company stock worth $26,384,359 over the last three months. 12.90% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE boosted its holdings in Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after acquiring an additional 3,055 shares in the last quarter. Ameritas Investment Partners Inc. raised its position in shares of Amprius Technologies by 2,043.2% during the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after purchasing an additional 9,072 shares during the period. Quarry LP bought a new position in shares of Amprius Technologies in the 3rd quarter worth $42,000. Rhumbline Advisers lifted its holdings in shares of Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock worth $42,000 after purchasing an additional 5,951 shares in the last quarter. Finally, Legal & General Group Plc grew its position in Amprius Technologies by 1,385.4% in the 2nd quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after purchasing an additional 9,684 shares during the period. 5.04% of the stock is owned by institutional investors and hedge funds.

Key Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Craig Hallum initiated coverage with a “Buy” and a $17 price target (about ~54% upside vs. recent levels), giving investors a near-term Street catalyst and added buy-side attention. Craig Hallum initiation
• Positive Sentiment: MarketBeat included AMPX in a “hot buys” roundup and highlighted an upcoming March earnings release as a potential growth-confirming catalyst; the write-up reiterates bullish revenue-growth forecasts and upside to mid-teens-plus targets. MarketBeat hot buys article
• Positive Sentiment: Analyst momentum: multiple firms have issued Buy/Outperform ratings and raised targets recently (Needham $20, Cantor Fitzgerald $16, Oppenheimer $17), and consensus sits around a “Moderate Buy” with a mid-teens target—supporting further upside if fundamentals/earnings meet expectations. MarketBeat analyst summary
• Neutral Sentiment: Institutional activity shows selective buying and position increases (e.g., Osterweis, Numerai and new stakes by Alberta Investment Management and others), which can underpin liquidity but are not definitive signals of immediate upside. Institutional ownership details
• Negative Sentiment: Insider selling: CTO Constantin Ionel Stefan sold 25,366 shares (avg. $10.16) and Director Kang Sun sold 61,251 shares (avg. $10.16) in late-February filings; repeated insider sales can raise governance/near-term sentiment concerns even if remaining holdings stay large. Insider trades alert

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.